King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
King Abdullah International Medical Research Centre, Jeddah, Saudi Arabia.
Womens Health (Lond). 2023 Jan-Dec;19:17455057231210094. doi: 10.1177/17455057231210094.
COVID-19 vaccines have provided fertile ground for research, especially with the unprecedented spread of misinformation about this disease and its vaccines. Among women, one of the most frequently reported side effects of the vaccine has been menstrual disturbance.
To investigate the perceived impact of COVID-19 vaccines on the menstrual cycle. In addition, the research seeks to identify factors that could predispose certain individuals to experience these effects, thereby contributing to a deeper understanding of the interplay between vaccines and menstrual health.
We conducted a retrospective observational cross-sectional study.
Any woman of menstruating age who received at least one dose of the COVID-19 vaccine and currently resides in Saudi Arabia was invited to complete an online questionnaire. The questionnaire compared menstruation characteristics-regularity, volume, intermenstrual bleeding, and dysmenorrhea-before and after receiving the COVID-19 vaccine, taking into consideration possible predisposing factors such as polycystic ovarian syndrome, contraceptives, or period-blocking pills.
Women without polycystic ovarian syndrome experienced less change in dysmenorrhea post-vaccine compared to those with polycystic ovarian syndrome (23.88% versus 37.78%, = 0.045). Women using hormonal contraceptives were about two times more likely to experience changes in volume compared to those not using contraceptives (odds ratio = 2.09, 95% confidence interval = 1.23-3.57, = 0.006). COVID-19 vaccine skeptics were about three times more likely to perceive changes in regularity post-vaccine compared to non-skeptics (odds ratio = 2.96, 95% confidence interval = 1.79-4.90, < 0.001). They were also three times more likely to perceive changes in volume post-vaccine (odds ratio = 3.04, 95% confidence interval = 1.95-4.74, < 0.001).
Our data suggest significant associations between COVID-19 skepticism, the use of hormonal contraceptives, and the reported post-vaccine menstrual disturbances. This underscores the importance of public education efforts aimed at dispelling misinformation and addressing controversies related to these vaccines.
COVID-19 疫苗为研究提供了肥沃的土壤,尤其是在这种疾病及其疫苗的错误信息空前传播的情况下。在女性中,疫苗最常报告的副作用之一是月经紊乱。
调查 COVID-19 疫苗对月经周期的感知影响。此外,该研究旨在确定可能使某些人更容易出现这些影响的因素,从而深入了解疫苗与月经健康之间的相互作用。
我们进行了回顾性观察性横断面研究。
任何年龄在月经期间的女性,只要至少接种过一剂 COVID-19 疫苗,并且目前居住在沙特阿拉伯,都被邀请填写在线问卷。该问卷比较了接种 COVID-19 疫苗前后的月经特征-规律性、出血量、经间期出血和痛经-并考虑了可能的诱发因素,如多囊卵巢综合征、避孕药或经期阻断丸。
与多囊卵巢综合征患者相比,无多囊卵巢综合征的女性在接种疫苗后痛经变化较小(23.88%对 37.78%,= 0.045)。使用激素避孕药的女性与不使用避孕药的女性相比,出血量变化的可能性约高出两倍(比值比= 2.09,95%置信区间= 1.23-3.57,= 0.006)。与非怀疑论者相比,COVID-19 疫苗怀疑论者在接种疫苗后感知到规律变化的可能性约高出三倍(比值比= 2.96,95%置信区间= 1.79-4.90,< 0.001)。他们在接种疫苗后感知到出血量变化的可能性也高出三倍(比值比= 3.04,95%置信区间= 1.95-4.74,< 0.001)。
我们的数据表明,COVID-19 怀疑、使用激素避孕药与报告的疫苗接种后月经紊乱之间存在显著关联。这突显了开展公众教育工作的重要性,旨在消除错误信息并解决与这些疫苗相关的争议。